Table 3 Absolute values of lung function indexes in healthy term controls, premature infants without bronchopulmonary dysplasia (BPD), and premature infants with BPD at different corrected ages.

From: Evolution and Determinants of Lung Function until Late Infancy among Infants Born Preterm

Ā Ā 

Control

Premature without BPD

Premature with BPD

Vt (ml)

6 mo

64.74 ± 8.35

(n = 86)

60.47 ± 11.62*

(n = 39)

58.41 ± 9.33***

(n = 53)

12 mo

88.23 ± 13.67

(n = 44)

88.46 ± 11.5

(n = 37)

74.09 ± 11.17***

(n = 38)

18 mo

107.4 ± 14.6

(n = 20)

102.7 ± 13.9

(n = 30)

95.0 ± 14.8

(n = 28)

24 mo

114.5 ± 8.3

(n = 10)

117 ± 14

(n = 16)

97.9 ± 22

(=21)

Rrs (kPa*s/L)

6 mo

4.31 ± 1.31

(n = 86)

4.65 ± 1.48

(n = 37)

5.43 ± 1.54***

(n = 45)

12 mo

3.24 ± 0.93

(n = 42)

3.24 ± 0.82

(n = 30)

4.06 ± 1.73**

(n = 35)

18 mo

2.53 ± 0.45

(n = 19)

3.22 ± 1.05*

(n = 24)

4.34 ± 2.56**

(n = 26)

24 mo

2.1 ± 0.9

(n = 10)

2.217 ± 0.39

(n = 14)

3.182 ± 1.29*

(n = 20)

Crs (ml/kPa)

6 mo

102.7 ± 29.9

(n = 86)

84.5 ± 18.4***

(n = 37)

75.2 ± 23.3***

(n = 45)

12 mo

140.9 ± 34.6

(n = 42)

122.4 ± 42.2*

(n = 30)

101.1 ± 19.62***

(n = 35)

18 mo

155.2 ± 25.4

(n = 19)

150.3 ± 25.5

(n = 24)

136.7 ± 30.2*

(n = 26)

24 mo

180 ± 33

(n = 10)

188 ± 41

(n = 14)

129.4 ± 50**

(n = 20)

V’maxFRC (ml/s)

6 mo

202.9 ± 98.3

(n = 97)

112.8 ± 54.2***

(n = 32)

101.7 ± 52.1***

(n = 46)

12 mo

282.5 ± 117.2

(n = 68)

227.4 ± 88.8*

(n = 33)

150.4 ± 65.6***

(n = 37)

18 mo

354.7 ± 134.1

(n = 33)

291.7 ± 110.8*

(n = 29)

203.5 ± 102.9***

(n = 26)

24 mo

360.1 ± 135.2

(n = 27)

399.6 ± 136.7

(n = 14)

220.2 ± 138.1**

(n = 20)

FEV0.5 (ml)

6 mo

235 ± 19

(n = 33)

209.5 ± 29**

(n = 10)

198.7 ± 31.2***

(n = 25)

12 mo

295.8 ± 17.2

(n = 25)

302.0 ± 25.1

(n = 8)

242.2 ± 50.1***

(n = 20)

18 mo

327.6 ± 19.9

(n = 25)

322.7 ± 33.0

(n = 12)

294.3 ± 57.7**

(n = 22)

24 mo

368 ± 26.5

(n = 14)

363.3 ± 46.1

(n = 10)

282.7 ± 56.4***

(n = 16)

FVC (ml)

6 mo

308.8 ± 39.2

(n = 33)

285.2 ± 49.2

(n = 10)

273.8 ± 55.7**

(n = 25)

12 mo

436.4 ± 36.0

(n = 25)

469 ± 42

(n = 8)

355 ± 63.8***

(n = 20)

18 mo

503.1 ± 41.8

(n = 25)

501.7 ± 56.3

(n = 12)

454.5 ± 88.0*

(n = 22)

24 mo

587.9 ± 55.7

(n = 14)

582.8 ± 99.4

(n = 10)

440.2 ± 107.7***

(n = 16)

FEF25–75 (ml/s)

6 mo

427.6 ± 29.4

(n = 33)

364.2 ± 53.2***

(n = 10)

355 ± 60.5***

(n = 25)

12 mo

523.4 ± 27.1

(n = 25)

515.5 ± 51.5

(n = 8)

387.7 ± 66.6***

(n = 20)

18 mo

573.4 ± 31.3

(n = 25)

554.1 ± 59.5

(n = 12)

503.8 ± 103.8**

(n = 22)

24 mo

637.1 ± 41.8

(n = 14)

626.4 ± 77.1

(n = 10)

478.3 ± 108.6***

(n = 16)

  1. *p < 0.05 compared with the control group; **p < 0.01 compared with the control group; ***p < 0.001 compared with the control group.
  2. Vt, tidal volume; Rrs, resistance of respiratory system, Crs, compliance of respiratory system; V’maxFRC, maximal flow at functional residual capacity; FEV0.5, forced expiratory volume at 0.5 s; FVC, forced vital capacity; FEF25–75, forced midexpiratory flow.